Publikationen von B. Eisensamer

Rammes, G.; Hosp, C.; Eisensamer, B.; Tanasic, S.; Nothdurfter, C.; Zieglgänsberger, W.; Rupprecht, R.: Identification of a Domain which Affects Kinetics and Antagonistic Potency of Clozapine at 5-HT3 Receptors. PLoS ONE 4 (8), doi: 10.1371/journal.pone.0006715 (2009)

Nothdurfter, C.; Eisensamer, B.; Rein, T.; Rammes, G.; Uhr, M.; Henes, K.; Wagner, E. M.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Functional Consequences of the accumulation of psychopharmacological drugs in "lipid rafts" on ligand-gated ion channels. Pharmacopsychiatry 40 (5), S. 247 - 247 (2007)

Eisensamer, B.; Uhr, M.; Meyr, S.; Gimpl, G.; Deiml, T.; Rammes, G.; Lambert, J. J.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antidepressants and antipsychotic drugs colocalize with 5-HT₃ receptors in raft-like domains. The Journal of Neuroscience 25 (44), S. 10198 - 10206 (2005)

Rammes, G.; Eisensamer, B.; Ferrari, U.; Shapa, M.; Gimpl, G.; Gilling, K.; Parsons, C.; Riering, K.; Hapfelmeier, G.; Bondy, B. et al.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Molecular Psychiatry 9 (9), S. 846 - 858 (2004)

Deiml, T.; Haseneder, R.; Zieglgänsberger, W.; Rammes, G.; Eisensamer, B.; Rupprecht, R.; Hapfelmeier, G.: α-Thujone reduces 5-HT3 receptor activity by an effect on the anonist-induced desensitization. Neuropharmacology 46, S. 192 - 201 (2004)

Rammes, G.; Eisensamer, B.; Ferrari, U.; Shapa, M.; Gimpl, G.; Gilling, K.; Parsons, C.; Riering, K.; Hapfelmeier, G.; Bondy, B. et al.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antipsychotic drugs antagonize human serotonin type 3 (5-HT₃) receptor currents in a noncompetitive manner [Image]. Molecular Psychiatry 9 (9), S. 818 - 818 (2004)

Deiml, T.; Haseneder, R.; Zieglgänsberger, W.; Baghai, T. C.; Eser, D.; Schule, C.; Ella, R.; Eisensamer, B.; Rupprecht, R.; Hapfelmeier, G.: alpha-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization. Pharmacopsychiatry 36 (5), S. 219 - 219 (2003)

Eisensamer, B.; Rammes, G.; Gimpl, G.; Shapa, M.; Ferrari, U.; Hapfelmeier, G.; Bondy, B.; Parsons, C.; Gilling, K.; Zieglgänsberger, W. et al.; Holsboer, F.; Rupprecht, R.: Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Pharmacopsychiatry 36 (5), S. 223 - 223 (2003)

Rupprecht, R.; Eisensamer, B.: Modulation of ligand-gated ion channels by antidepressants. Pharmacopsychiatry 36 (5), S. 258 - 258 (2003)

Hapfelmeier, G.; Tredt, C.; Haseneder, R.; Zieglgänsberger, W.; Eisensamer, B.; Rupprecht, R.; Rammes, G.: Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophysical Journal 84 (3), S. 1720 - 1733 (2003)

Eisensamer, B.; Rammes, G.; Gimpl, G.; Shapa, M.; Ferrari, U.; Hapfelmeier, G.; Bondy, B.; Parsons, C.; Gilling, K.; Zieglgänsberger, W. et al.; Holsboer, F.; Rupprecht, R.: Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Molecular Psychiatry 8 (12), S. 994 - 1007 (2003)